Price T Rowe Associates Inc Fibrogen Inc Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 116,000 shares of FGEN stock, worth $63,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,000

Previous 156,500 25.88%

Holding current value

$63,800

Previous $63,000 3.17%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.3 - $0.58 $12,150 - $23,490	-40,500 Reduced 25.88%	116,000 $61,000
Q3 2024 Nov 14, 2024	BUY	$0.33 - $1.26 $20,988 - $80,136	63,600 Added 68.46%	156,500 $63,000
Q2 2024 Aug 14, 2024	SELL	$0.89 - $2.36 $21,678 - $57,484	-24,358 Reduced 20.77%	92,900 $83,000
Q1 2024 May 15, 2024	BUY	$0.73 - $2.73 $4,273 - $15,981	5,854 Added 5.25%	117,258 $276,000
Q4 2023 Feb 14, 2024	BUY	$0.38 - $0.91 $15,466 - $37,037	40,700 Added 57.56%	111,404 $99,000
Q3 2023 Nov 14, 2023	BUY	$0.79 - $2.83 $19,276 - $69,052	24,400 Added 52.7%	70,704 $62,000
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $1.9 Million - $15.7 Million	-762,319 Reduced 94.27%	46,304 $126,000
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $1.91 Million - $3.01 Million	-119,511 Reduced 12.88%	808,623 $15.1 Million
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $11.9 Million - $15.9 Million	894,858 Added 2689.2%	928,134 $14.9 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $147,219 - $188,544	12,914 Added 63.42%	33,276 $433,000
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $23,335 - $38,089	2,939 Added 16.87%	20,362 $215,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $50,532 - $70,585	4,204 Added 31.8%	17,423 $209,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $182,662 - $283,099	-18,395 Reduced 58.19%	13,219 $186,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $4.73 Million - $12.4 Million	-464,872 Reduced 93.63%	31,614 $323,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $26 Million - $50 Million	-1,401,581 Reduced 73.84%	496,486 $13.2 Million
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $53.6 Million - $96.4 Million	-1,729,330 Reduced 47.67%	1,898,067 $65.9 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $135 Million - $178 Million	3,627,397 New	3,627,397 $135 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

39.9M

Call Options Held

343K

Put Options Held

100K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $51.6M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Fibrogen Inc Transaction History